Tag: RMB21.6
Huakang Biomed Announces First Annual Results Since Listing
Loss Reduced, Profit before Tax Excluding Listing Expenses amounted to RMB9.1 Million;
Continuous Focus on Research and Development;
Lying Strong Foundation for Future Growth
HONG KONG, March...